Growth Metrics

Masimo (MASI) Net Income towards Common Stockholders (2009 - 2026)

Masimo's quarterly Net Income towards Common Stockholders came in at $800000.0 in Q2 2026, up 100.37% year-on-year from $399267.1 in Q2 2025, and down 87.5% quarter-over-quarter from $6.4 million in Q1 2026.

Masimo has reported Net Income towards Common Stockholders for 18 years, with the latest figure at $800000.0 in Q2 2026.

  • For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 100.37% year-over-year to $800000.0; the trailing twelve-month figure through Apr 2026 stood at -$140.5 million (up 73.28% YoY), and the FY2026 full-year result was -$359.2 million, down 11.87% from the prior year.
  • Net Income towards Common Stockholders for Q2 2026 stood at $800000.0, down from $6.4 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $60.1 million in Q4 2023, with the low at -$284.6 million in Q4 2024.
  • Average Net Income towards Common Stockholders over 5 years is -$20.5 million, with a median of $8.5 million recorded in 2023.
  • Peak annual rise in Net Income towards Common Stockholders reached 172.73% in 2025, while the deepest fall reached 1550.76% in 2025.
  • Tracing MASI's Net Income towards Common Stockholders over 5 years: stood at $40.9 million in 2022, then jumped by 46.94% to $60.1 million in 2023, then slumped by 573.54% to -$284.6 million in 2024, then jumped by 45.85% to -$154.1 million in 2025, then jumped by 100.52% to $800000.0 in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $800000.0 (Q2 2026), $6.4 million (Q1 2026), and -$154.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Masimo 9.32 Bn 9.20 Bn 250.80 Mn 800,000.00

Historic Data

Download Data 🔒
DateValue
Apr 4, 2026 800,000.00
Jan 3, 2026 6.40 Mn
Sep 27, 2025 -154.10 Mn
Jun 28, 2025 6.40 Mn
Mar 29, 2025 -217.90 Mn
Dec 28, 2024 -284.60 Mn
Sep 28, 2024 -14.50 Mn
Jun 29, 2024 -8.80 Mn
Mar 30, 2024 -13.20 Mn
Dec 30, 2023 60.10 Mn
Sep 30, 2023 10.60 Mn
Jul 1, 2023 15.70 Mn
Apr 1, 2023 21.30 Mn
Dec 31, 2022 40.90 Mn
Oct 1, 2022 37.90 Mn
Jul 2, 2022 18.10 Mn
Apr 2, 2022 46.60 Mn
Jan 1, 2022 59.97 Mn
Oct 2, 2021 57.80 Mn
Jul 3, 2021 50.20 Mn
Apr 3, 2021 53.38 Mn
Jan 2, 2021 64.92 Mn
Sep 26, 2020 49.41 Mn
Jun 27, 2020 55.77 Mn
Mar 28, 2020 64.46 Mn
Dec 28, 2019 52.92 Mn
Sep 28, 2019 49.09 Mn
Jun 29, 2019 44.89 Mn
Mar 30, 2019 49.32 Mn
Dec 29, 2018 46.93 Mn
Sep 29, 2018 57.13 Mn
Jun 30, 2018 43.85 Mn
Mar 31, 2018 45.63 Mn
Dec 30, 2017 -7.74 Mn
Sep 30, 2017 35.85 Mn
Jul 1, 2017 45.14 Mn
Apr 1, 2017 51.53 Mn
Dec 31, 2016 225.72 Mn
Oct 1, 2016 27.77 Mn
Jul 2, 2016 30.02 Mn
Apr 2, 2016 27.58 Mn
Jan 2, 2016 28.63 Mn
Oct 3, 2015 18.93 Mn
Jul 4, 2015 18.30 Mn
Apr 4, 2015 18.78 Mn
Jan 3, 2015 30.91 Mn
Sep 27, 2014 14.96 Mn
Jun 28, 2014 14.05 Mn
Mar 29, 2014 22.59 Mn
Dec 28, 2013 9.25 Mn
Sep 28, 2013 15.49 Mn
Jun 29, 2013 14.65 Mn
Mar 30, 2013 16.40 Mn
Dec 29, 2012 12.25 Mn
Sep 29, 2012 13.56 Mn
Jun 30, 2012 17.77 Mn
Mar 31, 2012 15.77 Mn
Dec 31, 2011 14.17 Mn
Oct 1, 2011 14.82 Mn
Jul 2, 2011 16.91 Mn
Apr 2, 2011 18.15 Mn
Jan 1, 2011 33.57 Mn
Oct 2, 2010 16.69 Mn
Jul 3, 2010 13.92 Mn
Apr 3, 2010 26.16 Mn
Oct 3, 2009 13.32 Mn
Jul 4, 2009 13.25 Mn